253840 — Sugentech Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual cashflow statement for Sugentech, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-41,069	36,150	26,678	-17,378	-15,370
Depreciation
Amortisation
Non-Cash Items	66,496	3,939	22,677	-9,097	-7,085
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-11,977	-2,529	-22,544	9,555	10,099
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	14,333	38,955	30,428	-12,153	-7,517
Capital Expenditures	-4,438	-5,270	-16,001	-5,742	-1,951
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	4,037	-20,560	-25,936	7,733	8,336
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-401	-25,830	-41,937	1,990	6,385
Financing Cash Flow Items	45.9	228	113	217	9.02
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	683	35,940	-2,197	-19,444	-10,711
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	14,063	49,409	-14,034	-29,815	-11,685